Invest in the Future of Luxury Longevity: US Capital Global Securities Announces Up to $7.2 Million Offering for RECET Health
Explore an investment opportunity in RECET Health, a luxury wellness and longevity company pioneering an all-inclusive membership model for regenerative health, performance optimization, and healthy aging.
SAN FRANCISCO, AUGUST 2026 – US Capital Global Securities LLC, the SEC-registered broker-dealer affiliate of the global financial group US Capital Global, is pleased to present eligible investors with the opportunity to participate in a convertible note offering of up to $7.2 million for RECET Health (the “Company”).
RECET Health is building a new category of luxury wellness destination at the intersection of regenerative medicine, longevity science, and premium hospitality. As consumers increasingly invest in proactive health optimization rather than reactive healthcare, the Company is developing an exclusive private membership model that combines advanced diagnostics, physician-supervised regenerative therapies, recovery services, and five-star hospitality within a seamless wellness experience.
The investment opportunity comes as the global wellness economy is projected to reach approximately $5.6 trillion by 2030, with longevity and preventive health among its fastest-growing segments. RECET aims to capitalize on this trend by bringing together premium healthcare services and luxury hospitality under a scalable, subscription-based business model.
The Company’s flagship location, currently under development in Fort Lauderdale, Florida, will provide members with unlimited access to a comprehensive suite of cutting-edge wellness and recovery services through a simple annual membership, eliminating the traditional per-treatment pricing structure common throughout the industry.
The integrated experience combines hyperbaric oxygen therapy, cryotherapy, red light therapy, IV therapy, peptide protocols, exosome therapy, platelet-rich plasma (PRP), and precision diagnostics. Every member also receives personalized wellness planning delivered under expert medical supervision.
“We believe the future of healthcare is proactive rather than reactive,” said Jason Holzberg, CEO of RECET Health. “RECET was created to bring together the world’s most advanced longevity therapies within an elevated hospitality experience that makes optimizing health both accessible and enjoyable for our members. Our goal is to redefine how people approach long-term wellness, recovery, and human performance.”
The financing is intended to support the completion and launch of the Company’s flagship Fort Lauderdale location, provide working capital, and execute the Company’s broader expansion strategy. According to management, RECET plans a disciplined rollout of approximately one new location annually, targeting affluent wellness markets including Palm Beach, Dallas, Austin, Scottsdale, Aspen, and Park City. The Company also plans to expand internationally through an established strategic partnership in Spain.
“RECET Health has developed a differentiated platform that combines luxury hospitality with physician-supervised regenerative medicine under a recurring membership model,” said Charles Towle, CEO of US Capital Global Securities LLC. “We believe the Company’s experienced leadership team, scalable expansion strategy, and focus on affluent, high-growth markets position it well to capitalize on one of the most compelling trends in healthcare today. We are pleased to be assisting RECET Health with this offering and invite eligible investors to learn more about this growth opportunity.”
About RECET Health
RECET Health is a luxury wellness and longevity company developing premium membership-based social wellness clubs that integrate regenerative medicine, recovery therapies, advanced diagnostics, and personalized health optimization within a five-star hospitality environment. The Company’s flagship location is currently under development in Fort Lauderdale, Florida, with plans for future expansion into leading luxury wellness markets across the United States and internationally. Through its unlimited membership model, RECET seeks to redefine the future of preventive healthcare, performance optimization, and healthy aging. Learn more at www.recethealth.com.
About US Capital Global
US Capital Global Securities LLC (“USCGS”) serves as the FINRA-member broker-dealer division of US Capital Global, specializing in facilitating growth-stage investments. Since 1998, US Capital Global has been dedicated to providing lower middle market businesses and investors with sophisticated investment opportunities. For further details about US Capital Global Securities or this investment opportunity, Pankaj Vashisth, Partner and CCO, at pv@uscapital.com or call +1 415-999-0310.
Disclaimer: USCGS or its affiliates may provide advice to, be compensated by, have other business relationships with, or may from time to time acquire, hold, or sell a position in the securities of the issuers mentioned herein. Any offer or solicitation shall be made only pursuant to the confidential private placement memorandum. View USCGS’ Form CRS at www.uscapglobalsecurities.com/crs.html.
Download a PDF of this Press Release
Media Q&A / FAQs
What is this announcement about?
This press release announces that US Capital Global Securities LLC is presenting eligible investors with the opportunity to participate in a convertible note offering of up to $7.2 million for RECET Health.
What does RECET Health do?
RECET Health is developing luxury wellness and longevity destinations that combine regenerative medicine, advanced diagnostics, recovery therapies, personalized health optimization, and premium hospitality within a private membership model.
What makes RECET Health’s business model different?
The Company is developing an all-inclusive annual membership model designed to give members ongoing access to a broad range of wellness and recovery services instead of relying primarily on traditional per-treatment pricing.
Where is RECET Health developing its first location?
RECET Health’s flagship location is currently under development in Fort Lauderdale, Florida.
What services are expected to be available to members?
The press release states that RECET Health plans to offer services including hyperbaric oxygen therapy, cryotherapy, red light therapy, IV therapy, peptide protocols, exosome therapy, platelet-rich plasma (PRP), precision diagnostics, and personalized wellness planning under expert medical supervision.
What market trend is RECET Health targeting?
The Company is targeting growing consumer demand for proactive health optimization, longevity, preventive healthcare, recovery, and healthy aging, alongside continued growth in the global wellness economy.
What will the financing be used for?
The financing is intended to support completion and launch of the flagship Fort Lauderdale location, provide working capital, and support the Company’s broader expansion strategy.
Where does RECET Health plan to expand?
According to management, RECET Health plans a disciplined rollout of approximately one new location annually, targeting affluent wellness markets including Palm Beach, Dallas, Austin, Scottsdale, Aspen, and Park City, with international expansion also planned through a strategic partnership in Spain.
How does RECET Health describe its approach to healthcare and wellness?
RECET Health describes its approach as proactive rather than reactive, combining physician-supervised longevity therapies with premium hospitality and personalized wellness planning.
How can eligible investors learn more about the opportunity?
The press release includes a link inviting eligible investors to review further information about the offering through US Capital Global Securities.
Who is the contact for more information?
The press release lists Pankaj Vashisth, Partner and CCO, as the contact for further details about US Capital Global Securities or the RECET Health investment opportunity, with email and phone contact information provided on the page.
Are there important offer or disclosure notes?
Yes. The page states that any offer or solicitation shall be made only pursuant to the confidential private placement memorandum and includes disclosures regarding US Capital Global Securities and its affiliates.